For paclitaxel resistance, the following miRNAs are relevant, miR-17-5P for the target PTEN in ovarian cancer[160], miR-30c for the targets VIM, IL-11 in breast cancer[161], miR-125b for Sema4C and Bak1 in breast cancer, and miR-100 for mTOR, miR-145 for P-gp in ovarian cancer[162], and miR-181a for PTEN in NSCLC[163]. This evidence concerns the gene PGP and breast carcinoma.